Novo Nordisk A/S (OTC Pink - Current Information:NONOF)
| 157.40 Delayed Data As of Mar 31 |  +1.22 / +0.78%Today’s Change | 94.75 Today|||52-Week Range 160.25 | +15.30% Year-to-Date |
Latest NONOF News | Press Releases
Today’s Trading
| Previous close | 156.18 |
| Today’s open | 158.72 |
| Day’s range | 157.40 - 160.25 |
| Volume | 1,888 |
| Average volume (3 months) | 14,265 |
| Market cap | $269.6B |
Data as of 03/31/2023
Growth & Valuation
| Earnings growth (last year) | +4.77% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +11.71% |
| P/E ratio | -- |
| Price/Sales | 12.24 |
| Price/Book | 29.56 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $25.0B |
| Annual profit (last year) | $7.8B |
| Net profit margin | 31.38% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bagsværd, Capital Region |
Forecasts
Chart unavailable
